Reviewed by Dr. Younghun Cho, PharmD
This product scores very high for its multi-strain, evidence-based formula, superior delivery system (enteric coating), and convenient shelf-stability.
Pharmacist's Verdict
Jarro-Dophilus EPS is a well-formulated, reliable daily probiotic from a reputable brand that is excellent for general gut health support. Its special enteric-coated capsule is a key feature that helps ensure the live bacteria survive stomach acid to do their job.
Ingredient Analysis
Details pending pharmacist review.
Details pending pharmacist review.
Details pending pharmacist review.
Pros & Cons
Pros
- Contains eight different, well-studied strains of beneficial bacteria to support overall gut health.
- Features a special coating (EnteroGuard) that protects the live bacteria from stomach acid, helping them reach the intestines alive.
- Shelf-stable, meaning it does not require refrigeration, which is very convenient for storage and travel.
- Made by Jarrow Formulas, a brand with a strong reputation for quality and testing in the supplement industry.
Cons
- More expensive than many basic, single-strain probiotics on the market.
- May cause temporary gas, bloating, or digestive upset for the first few days of use as your body adjusts.
- People who are severely immunocompromised or critically ill should talk to a doctor before taking any probiotic supplement.
References
- 1.Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis.
Siafis S, Wu H, Wang D, et al., Molecular psychiatry, 2023 · PubMed
- 2.Diagnostic performance of ultrasound in acute cholecystitis: a systematic review and meta-analysis.
Huang SS, Lin KW, Liu KL, et al., World journal of emergency surgery : WJES, 2023 · PubMed
- 3.Psychosocial safety climate: a multilevel theory of work stress in the health and community service sector.
Dollard MF, McTernan W, Epidemiology and psychiatric sciences, 2011 · PubMed
- 4.A critical overview of emotion processing assessment in non-affective and affective psychoses.
Gorrino I, Rossetti MG, Girelli F, et al., Epidemiology and psychiatric sciences, 2024 · PubMed
- 5.Reducing mental health-related stigma in primary health care settings in low- and middle-income countries: a systematic review.
Heim E, Kohrt BA, Koschorke M, et al., Epidemiology and psychiatric sciences, 2018 · PubMed